JP2011510120A5 - - Google Patents

Download PDF

Info

Publication number
JP2011510120A5
JP2011510120A5 JP2010542410A JP2010542410A JP2011510120A5 JP 2011510120 A5 JP2011510120 A5 JP 2011510120A5 JP 2010542410 A JP2010542410 A JP 2010542410A JP 2010542410 A JP2010542410 A JP 2010542410A JP 2011510120 A5 JP2011510120 A5 JP 2011510120A5
Authority
JP
Japan
Prior art keywords
group
substituted
functional group
unsubstituted
moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010542410A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011510120A (ja
JP5514736B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/030762 external-priority patent/WO2009089542A2/en
Publication of JP2011510120A publication Critical patent/JP2011510120A/ja
Publication of JP2011510120A5 publication Critical patent/JP2011510120A5/ja
Application granted granted Critical
Publication of JP5514736B2 publication Critical patent/JP5514736B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010542410A 2008-01-11 2009-01-12 ポリオキサゾリン共重合体の多機能形態およびそれを含む薬物組成物 Active JP5514736B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2068408P 2008-01-11 2008-01-11
US61/020,684 2008-01-11
US2933708P 2008-02-16 2008-02-16
US61/029,337 2008-02-16
PCT/US2009/030762 WO2009089542A2 (en) 2008-01-11 2009-01-12 Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

Publications (3)

Publication Number Publication Date
JP2011510120A JP2011510120A (ja) 2011-03-31
JP2011510120A5 true JP2011510120A5 (enExample) 2013-06-27
JP5514736B2 JP5514736B2 (ja) 2014-06-04

Family

ID=40853790

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010542410A Active JP5514736B2 (ja) 2008-01-11 2009-01-12 ポリオキサゾリン共重合体の多機能形態およびそれを含む薬物組成物

Country Status (7)

Country Link
US (2) US8110651B2 (enExample)
EP (3) EP2669313B1 (enExample)
JP (1) JP5514736B2 (enExample)
KR (1) KR101486449B1 (enExample)
CN (1) CN101959934B (enExample)
DK (1) DK3042922T3 (enExample)
WO (1) WO2009089542A2 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101706B2 (en) 2008-01-11 2012-01-24 Serina Therapeutics, Inc. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
CN101959934B (zh) * 2008-01-11 2012-12-12 塞瑞纳治疗公司 聚噁唑啉共聚物的多官能形式和包含它的药物组合物
WO2010006282A2 (en) * 2008-07-10 2010-01-14 Serina Therapeutics, Inc. Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds
TR201909167T4 (tr) 2011-01-04 2019-07-22 Gatt Tech B V Elektrofilik olarak aktive edilmiş polioksazolinden derive edilen çapraz bağlı polimerler ve implantlar.
CN102731791B (zh) * 2011-04-13 2016-04-13 北京大学 温度敏感型嵌段共聚物及其水凝胶和其用途
US8383093B1 (en) 2011-11-01 2013-02-26 Serina Therapeutics, Inc. Subcutaneous delivery of poly(oxazoline) conjugates
US20140271527A1 (en) * 2011-11-01 2014-09-18 Serina Therapeutics, Inc. Subcutaneous delivery of polymer conjugates of therapeutic agents
BR112014016338B1 (pt) 2012-01-02 2021-01-26 Universiteit Gent polímeros de polioxazolina e processos para a sua preparação, conjugados destes polímeros e usos médicos dos mesmos
CN104271638B (zh) 2012-03-16 2016-11-02 本德尔分析控股公司 源于亲核活性聚噁唑啉的交联聚合物和医用品
CA2891673C (en) 2012-11-15 2025-10-07 Apellis Pharmaceuticals Inc Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
CN106715533B (zh) * 2014-07-31 2020-03-13 塞瑞纳治疗公司 聚恶唑啉抗体药物结合物
MY179853A (en) 2014-09-26 2020-11-18 Alcon Inc Polymerizable polysiloxanes with hydrophilic substituents
BR112017006943B1 (pt) 2014-10-06 2020-12-01 Gatt Technologies B.V produto hemostático poroso adesivo de tecido
JP6968787B2 (ja) 2015-10-07 2021-11-17 アペリス・ファーマシューティカルズ・インコーポレイテッドApellis Pharmaceuticals, Inc. 投与レジメン
CN105418911A (zh) * 2015-12-29 2016-03-23 南京工业大学 一种聚(2-r-2-噁唑啉)嵌段聚(肌氨酸)双亲性嵌段共聚物的制备方法
US11040107B2 (en) 2017-04-07 2021-06-22 Apellis Pharmaceuticals, Inc. Dosing regimens and related compositions and methods
DE102018000650A1 (de) * 2018-01-27 2019-08-01 Friedrich-Schiller-Universität Jena Verfahren zur Bestimmung von Verunreinigungen in Polyalkylenethern oder Polyalkylenaminen und dessen Verwendung
US12485181B2 (en) 2019-06-28 2025-12-02 Serina Therapeutics (Al), Inc. Polyoxazoline-drug conjugates with novel pharmacokinetic properties
CN113354811B (zh) * 2020-02-19 2024-05-07 华东理工大学 一种侧链含有氨基和/或羟基的噁唑啉聚合物,其制备方法及应用
CN112661961B (zh) * 2020-12-28 2022-05-06 中国科学院长春应用化学研究所 两亲性聚噁唑啉共聚物、其制备方法及应用
US12233132B2 (en) 2021-02-09 2025-02-25 Serina Therapeutics, Inc. Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same
AU2022336664A1 (en) 2021-09-03 2024-01-18 CureVac SE Novel lipid nanoparticles for delivery of nucleic acids comprising phosphatidylserine
AU2022336209B2 (en) 2021-09-03 2025-10-16 CureVac SE Novel lipid nanoparticles for delivery of nucleic acids
KR20230044782A (ko) 2021-09-27 2023-04-04 삼성전자주식회사 패치 안테나를 포함하는 안테나 구조 및 이를 포함하는 전자 장치
US20250027108A1 (en) 2021-10-29 2025-01-23 CureVac SE Improved circular rna for expressing therapeutic proteins
US20250099614A1 (en) 2022-01-28 2025-03-27 CureVac SE Nucleic acid encoded transcription factor inhibitors
AU2024233180A1 (en) 2023-03-08 2025-09-25 CureVac SE Novel lipid nanoparticle formulations for delivery of nucleic acids
WO2024230934A1 (en) 2023-05-11 2024-11-14 CureVac SE Therapeutic nucleic acid for the treatment of ophthalmic diseases

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4709039A (en) * 1986-03-21 1987-11-24 The Dow Chemical Company Vinyloxazoline monomer and preparation thereof
WO1990002144A1 (en) 1988-08-22 1990-03-08 Fused Kontacts Of Chicago, Inc. Compositions for making improved gas permeable contact lenses
US5166322A (en) 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
US5130126A (en) 1990-07-09 1992-07-14 Nippon Oil & Fats Co., Ltd. Polymer-drug conjugate and a method of producing it
US5416071A (en) 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5635571A (en) 1995-06-30 1997-06-03 Cornell Research Foundation, Inc. Polymerizable macromonomers and polymers prepared therefrom
US6753165B1 (en) 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
EP1012184B1 (en) 1997-07-14 2007-10-10 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins
JO2291B1 (en) 1999-07-02 2005-09-12 اف . هوفمان لاروش ايه جي Erythropoietin derivatives
CZ299516B6 (cs) 1999-07-02 2008-08-20 F. Hoffmann-La Roche Ag Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
DE19936014C2 (de) 1999-08-04 2003-04-03 Zf Lemfoerder Metallwaren Ag Gummilager mit axialer Dämpfung
AU2001289307A1 (en) 2000-04-06 2001-10-23 Pharmacia Corporation Chemically-modified myelopoietin conjugates
CN1458846A (zh) 2000-09-08 2003-11-26 格莱风治疗公司 促红细胞生成性合成蛋白
ATE421535T1 (de) 2000-10-16 2009-02-15 Chugai Pharmaceutical Co Ltd Peg-modifiziertes erythropoietin
US6759496B2 (en) * 2000-12-18 2004-07-06 Bausch & Lomb Incorporated Poly(2-oxazoline) biomedical devices
AU2002233230B2 (en) 2000-12-20 2007-02-01 F. Hoffmann-La Roche Ag Erythropoietin conjugates
KR100401296B1 (ko) 2000-12-27 2003-10-11 드림바이오젠 주식회사 수식물질에 의해 수식된 단백질 변이체 및 이것의 제조방법
US7077939B1 (en) 2001-06-18 2006-07-18 The Texas A&M University System Method and apparatus for nanoparticle transport and detection
US6908963B2 (en) 2001-10-09 2005-06-21 Nektar Therapeutics Al, Corporation Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
US7125843B2 (en) 2001-10-19 2006-10-24 Neose Technologies, Inc. Glycoconjugates including more than one peptide
JP3984541B2 (ja) * 2001-12-26 2007-10-03 財団法人川村理化学研究所 星型ポリオキサゾリンからなる粒子およびその製造方法
US20060051315A1 (en) 2002-02-01 2006-03-09 Scaria Puthupparampil V Polymers for delivering peptides and small molecules in vivo
EP1344810A1 (en) 2002-03-13 2003-09-17 Infineum International Limited Fuel additive compositions for diesel engine equipped with a particulate trap
US7074755B2 (en) 2003-05-17 2006-07-11 Centocor, Inc. Erythropoietin conjugate compounds with extended half-lives
BRPI0410863A (pt) 2003-05-30 2006-07-04 Centocor Inc formação de novos conjugados de eritropoietina usando transglutaminase
PT1512736T (pt) 2003-09-05 2018-05-29 Infineum Int Ltd Composições estabilizadas de aditivos para gasóleo
US8057821B2 (en) * 2004-11-03 2011-11-15 Egen, Inc. Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
GB2438982A (en) 2004-12-22 2007-12-12 Ambrx Inc Compostions containing, methods involving, and uses of non-natural amino acids and polypeptides
WO2007010552A2 (en) 2005-03-17 2007-01-25 Serum Institute Of India Limited N- terminal peg conjugate of erythropoietin
CN106046370A (zh) 2007-02-28 2016-10-26 塞瑞纳治疗公司 聚噁唑啉poz化合物、合成其的方法、以及靶分子‑poz偶联物
CN101959934B (zh) 2008-01-11 2012-12-12 塞瑞纳治疗公司 聚噁唑啉共聚物的多官能形式和包含它的药物组合物
US8101706B2 (en) * 2008-01-11 2012-01-24 Serina Therapeutics, Inc. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

Similar Documents

Publication Publication Date Title
JP2011510120A5 (enExample)
Jäger et al. Branched and linear poly (ethylene imine)-based conjugates: synthetic modification, characterization, and application
Das et al. Activated ester containing polymers: opportunities and challenges for the design of functional macromolecules
JP5312050B2 (ja) 分割型の分解性重合体とそれから生成される複合体
Yang et al. Synthesis of multifunctional polymers through the Ugi reaction for protein conjugation
CA2824093C (en) Polymeric prodrug with a self-immolative linker
CN101835496B (zh) 靶向羟基磷灰石的多臂聚合物以及由其制造的偶联物
Günay et al. Standing on the shoulders of Hermann Staudinger: Post‐polymerization modification from past to present
Riber et al. Self‐Immolative linkers literally bridge disulfide chemistry and the realm of Thiol‐free drugs
JP5514736B2 (ja) ポリオキサゾリン共重合体の多機能形態およびそれを含む薬物組成物
Schönemann et al. Sulfobetaine methacrylate polymers of unconventional polyzwitterion architecture and their antifouling properties
Neri-Cruz et al. A guide to functionalisation and bioconjugation strategies to surface-initiated polymer brushes
Li et al. Multifunctional photodegradable polymers for reactive micropatterns
EP2412744A2 (en) Method for preparing branched functionalised polymers using branched polyol cores
JP2011174077A (ja) 脂肪族生物分解性リンカーに基づく放出可能なポリマー複合体
Choi et al. Functionalized N-Heterocyclic Carbene Monolayers on Gold for Surface-Initiated Polymerizations
He et al. Postpolymerization modification using less cytotoxic activated ester polymers for the synthesis of biological active polymers
JP2019535710A5 (enExample)
Gevrek et al. Succinimidyl carbonate-based amine-reactive polymer brushes: facile fabrication of functional interfaces
Kanto et al. Mixed polyplex micelles with thermoresponsive and lysine-based zwitterionic shells derived from two poly (vinyl amine)-based block copolymers
US6468522B1 (en) Controlled release of thioamide moiety-containing therapeutic agents
Trimaille et al. SG1-Functionalized Peptides as Precursors for Polymer− Peptide Conjugates: A Straightforward Approach
JP2008304427A (ja) バイオデバイスおよびその製造方法、並びにバイオセンサー
KR102668424B1 (ko) 분해성 폴리에틸렌글리콜 유도체
HRP20150247T1 (hr) Postupci za dobijanje polimernih reagenasa